JOHNSON & JOHNSON
NEW BRUNSWICK NJ · SEC CIK 0000200406
$6.52亿2026Q1 申报市值
16持仓数
99.0%前十大占比 · 第一大 39.6%
0 / 1新建仓 / 清仓
26Q126Q2
前十大持仓 占组合比例
2026Q1 买入最多 按季末市值估算
本季没有买入
2026Q1 卖出最多 按季末市值估算
RLYB 减仓-$3,124.67万
LYEL 清仓-$168.94万
Nano-X Imaging L 减仓-$17.09万
2026Q1 持仓明细 点表头排序
导出 CSV 🔒| 代码 | 名称 | 市值 ▼ | 占比 | 股数 | 变动股数 | 变动 | 估算买卖额 | 操作 |
|---|---|---|---|---|---|---|---|---|
| PTGX | Protagonist Therapeutics Inc. | $2.58亿 | 39.57% | 2,449,183 | 0 | 0.0% | — | 不变 |
| NBTX | Nanobiotix S.A. | $1.74亿 | 26.61% | 5,623,816 | 0 | 0.0% | — | 不变 |
| MGTX | MeiraGTx Holdings plc | $5,751.16万 | 8.82% | 6,641,064 | 0 | 0.0% | — | 不变 |
| RAPP | Rapport Therapeutics, Inc. | $5,583.75万 | 8.56% | 1,784,517 | 0 | 0.0% | — | 不变 |
| — | CVRx, Inc. | $3,807.52万 | 5.84% | 4,024,861 | 0 | 0.0% | — | 不变 |
| CTNM | Contineum Therapeutics Inc. | $2,584.80万 | 3.96% | 1,979,173 | 0 | 0.0% | — | 不变 |
| LEGN | Legend Biotech Corporation | $1,473.59万 | 2.26% | 814,586 | 0 | 0.0% | — | 不变 |
| XNCR | Xencor, Inc. | $902.16万 | 1.38% | 748,062 | 0 | 0.0% | — | 不变 |
| PRCT | Procept BioRobotics Corporation | $895.21万 | 1.37% | 357,939 | 0 | 0.0% | — | 不变 |
| FATE | Fate Therapeutics, Inc. | $405.49万 | 0.62% | 3,379,064 | 0 | 0.0% | — | 不变 |
| NMRA | Neumora Therapeutics, Inc. | $360.64万 | 0.55% | 1,849,445 | 0 | 0.0% | — | 不变 |
| RLYB | Rallybio Corporation | $137.15万 | 0.21% | 152,901 | -3,483,462 | -95.8% | -$3,124.67万 | 减仓 |
| VOR | Vor Biopharma, Inc. | $95.86万 | 0.15% | 53,732 | 0 | 0.0% | — | 不变 |
| LAB | Standard BioTools, Inc. | $28.68万 | 0.04% | 311,967 | 0 | 0.0% | — | 不变 |
| — | Nano-X Imaging Ltd. | $18.97万 | 0.03% | 83,554 | -75,298 | -47.4% | -$17.09万 | 减仓 |
| — | Adicet Bio, Inc. | $15.51万 | 0.02% | 22,779 | 0 | 0.0% | — | 不变 |
| LYEL | Lyell Immunopharma, Inc. | $0 | 0.00% | 0 | -54,887 | -100.0% | -$168.94万 | 清仓 |